Crucial Role of N Terminus in Function of Cardiac L-type Ca2+ Channel and Its Modulation by Protein Kinase C*

Elena Shistik, Tatiana Ivanina, Yakov Blumenstein, and Nathan DascalDagger

From the Department of Physiology and Pharmacology, Sackler School of Medicine, Tel Aviv University, Ramat Aviv 69978, Israel

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The role of the cytosolic N terminus of the main subunit (alpha 1C) of cardiac L-type voltage-dependent Ca2+ channel was studied in Xenopus oocyte expression system. Deletion of the initial 46 or 139 amino acids (a.a.) of rabbit heart alpha 1C caused a 5-10-fold increase in the whole cell Ca2+ channel current carried by Ba2+ (IBa), as reported previously (Wei, X., Neely, A., Olcese, R., Lang, W., Stefani, E., and Birnbaumer, L. (1996) Recept. Channels 4, 205-215). The plasma membrane content of alpha 1C protein, measured immunochemically, was not altered by the 46-a.a. deletion. Patch clamp recordings in the presence of a dihydropyridine agonist showed that this deletion causes a ~10-fold increase in single channel open probability without changing channel density. Thus, the initial segment of the N terminus affects channel gating rather than expression. The increase in IBa caused by coexpression of the auxiliary beta 2A subunit was substantially stronger in channels with full-length alpha 1C than in 46- or 139-a.a. truncated mutants, suggesting an interaction between beta 2A and N terminus. However, only the I-II domain linker of alpha 1C, but not to N or C termini, bound beta 2A in vitro. The well documented increase of IBa caused by activation of protein kinase C (PKC) was fully eliminated by the 46-a.a. deletion. Thus, the N terminus of alpha 1C plays a crucial role in channel gating and PKC modulation. We propose that PKC and beta  subunit enhance the activity of the channel in part by relieving an inhibitory control exerted by the N terminus. Since PKC up-regulation of L-type Ca2+ channels has been reported in many species, we predict that isoforms of alpha 1C subunits containing the initial N-terminal 46 a.a. similar to those of the rabbit heart alpha 1C are widespread in cardiac and smooth muscle cells.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

In the heart, Ca2+ current via the voltage-dependent L-type channels (dihydropyridine-sensitive) underlies the plateau of the action potential and provides calcium ions necessary for initiation of cardiac cell contraction (2). Similar channels are found in smooth muscle, where they play a major role in regulation of tonus and contraction (3, 4), and in the nervous system (5, 6). L-type channels are composed of the following three subunits: the main, pore-forming alpha 1C, the cytosolic beta 2, and the alpha 2delta subunit which is mostly extracellular (5, 7-11). alpha 1C contains four homologous membrane domains numbered I-IV, each one with six transmembrane segments and a re-entrant P-loop that forms the pore lining; N- and C-terminal domains and the linkers connecting the domains I-II, II-II, and II-IV are cytosolic (see Ref. 7 for review, and see Fig. 6A for a scheme). The C terminus was implicated in Ca2+- and voltage-dependent inactivation (12-15) and modulation by protein kinase A (16-19); linker I-II contains the binding site for the beta  subunit (20, 21).

Cardiac and smooth muscle L-type channels are tightly regulated by hormonal and neuronal signals via G proteins and protein kinases (22, 23). Protein kinase C (PKC)1 is one of such regulators; its actions appear to be tissue- and species-specific. PKC activators, such as phorbol esters and diacylglycerols, increase Ca2+ channel currents in cardiac and smooth muscle cells of various mammals (24-33), and PKC has been implicated in mediating the stimulation of Ca2+ channels by intracellular ATP (34), angiotensin II (26), glucocorticoids (28), pituitary adenylate cyclase-activating polypeptide (33), and arginine-vasopressin (32). PKC up-regulation results from changes in channel gating because it is accompanied by an increase in single channel open probability, Po (30, 35, 36). In many cases, a biphasic effect of PKC activators has been described, with an increase followed by a later decrease (25, 27, 30), and some preparations such as adult guinea pig heart cells (37, 38) respond to phorbol esters only by a decrease in Ca2+ currents, an effect that may not be mediated by PKC (38). The biphasic response to PKC stimulators is fully reconstituted when expression of L-type channels in Xenopus oocytes is directed by RNA extracted from rat heart (39, 40) or cRNA of rabbit cardiac alpha 1C subunit (39). Increase of Ca2+ channel activity by phorbol esters has also been observed in a mammalian cell line (baby hamster kidney) expressing the rabbit cardiac alpha 1C (36). The potentiation by phorbol esters of Ca2+ channels expressed in the oocytes is mediated by PKC because it is mimicked by diacylglycerols and blocked by specific PKC inhibitors (39, 40).

Both alpha 1C and beta  are substrates for PKC-catalyzed phosphorylation (Ref. 41 and references therein). alpha 1C subunit has been recognized as the target for the Ca2+ channel enhancement caused by PKC, since coexpression of the auxiliary subunits was not necessary to reproduce the effect of phorbol esters; on the contrary, coexpression of the beta  subunit weakened the enhancement suggesting a modulatory effect for this subunit (39). However, it is not known which part of alpha 1C is involved in the PKC action. alpha 1C isoforms cloned from rat brain (42) and human heart (43) are not up-regulated by PKC (43, 44), suggesting that the site of PKC action lies in one of the variable regions. More specifically, Bouron et al. (43) proposed that phosphorylation of the initial segment of the N terminus of the rabbit heart isoform may account for PKC potentiation, but this hypothesis has not been tested. It was unclear how this part of alpha 1C can affect the function of the channel, because in a recent publication Wei et al. (1) reported that deletion of up to 120 initial N-terminal amino acids strongly increased the whole cell Ca2+ channel current and, proportionally, the total gating charge movement but did not affect the voltage dependence of the charge movement or of the macroscopic current activation. It has been proposed (1) that the N-terminal deletion causes an increase in the amount of functional channels (hence the increase in total gating charge movement) but does not affect channel function.

In the beginning of this study we set out to test which part of alpha 1C accounts for the PKC-induced enhancement of the rabbit heart L-type channel, using deletion and single-site mutagenesis and expression in Xenopus oocytes. We found that, as predicted by Bouron et al. (43), deletion of the first 46 a.a. (which are thought to be unique to the rabbit heart isoform) eliminates the PKC-induced enhancement. To understand whether and how the N terminus affects the function of the channel, we have undertaken a more elaborate study of the properties of N-terminal deletion mutants and GST fusion proteins. Immunochemical and single channel measurements demonstrated that N-terminal deletions do not increase channel expression but rather enhance activation on single channel level. We find evidence for an interplay between N terminus, PKC, and the beta  subunit, although we could not detect any direct binding between N terminus and beta . Our results point to the possibility that potentiation of L-type Ca2+ channels by PKC, and part of the enhancement caused by the beta subunit, may result from attenuation of a tonic inhibitory control exerted by the N terminus. Furthermore, since the enhancing effect of PKC on L-type Ca2+ channels is widespread among mammalian species, our data suggest that alpha 1C isoforms with N termini of the "rabbit heart" type must also be widespread.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

DNA Constructs and mRNA-- cDNAs of rabbit heart alpha 1C (pCAH), rabbit heart beta 2A, and skeletal muscle alpha 2/delta subunits were prepared and used as described previously (45, 46). The cDNAs of the following mutants of alpha 1C were made within the original pCAH construct: Delta N88-139; st1665; S533I; S1575A (16). A PCR-based approach was designed for engineering all the other constructs used in this work. In an attempt to improve the expression of channels composed of alpha 1C alone, we subcloned the coding sequence of alpha 1C into a high expression vector, pGEM-SB, derived from pGEM-HE which contains a 50-base 5'-untranslated region and a 300-base 3'-untranslated region from Xenopus alpha -globin (47). pGEM-SB was produced by a standard PCR procedure used to extend the polylinker which now includes the following restriction sites: SmaI, BamHI, SalI, ClaI, BstEII, EcoRI, XbaI, and HindIII. By using standard PCR procedures, a SalI site was created immediately preceding the initial ATG of alpha 1C, and a HindIII site was created following the termination codon. After a series of intermediate subcloning and ligation steps, the coding sequence of alpha 1C was inserted between SalI and HindIII sites of pGEM-SB. The resulting cDNA was termed alpha 1C-SB; for synthesis of sense RNA with T7 polymerase, it was linearized with NheI. This procedure did not significantly improve the currents directed by the expression of alpha 1C RNA alone, as compared with pCAH, but provided a convenient tool for the creation of N-terminal deletion mutants. The cDNA of the neuronal alpha 1C isoform, rbC-II, was kindly provided by T. P. Snutch (University of British Columbia; see Ref. 42); this DNA was injected directly into the nuclei.

To create alpha 1C N-terminal truncations, PCR amplification with Vent polymerase (New England Biolabs) was performed using 100 ng of WT alpha 1C cDNA as template for 25 cycles of 30 s at 95 °C, 1 min at 55 °C, and 2 min at 72 °C. For each deletion mutant unique forward and reverse primers were used, with a forward primer creating a SalI site followed by an initiation codon and then by the original WT alpha 1C sequence starting from the desired base. For Delta N2-46, the forward primer was 5'-AT GTC GAC TAA ACC ATG G330GT TCC AAC TAT GG-3'. The reverse primer was 5'-GCT AAG GCC ACA CAA TTG GC-3', which is complementary to nucleotides 687-706 and includes an endogenous unique MfeI site. The restriction sites SalI and MfeI are underlined, respectively. To create Delta N2-139, the forward primer was 5'-TAG CCG GTC GAC ATG A609AG AAC CCC ATC CGG A-3'. Reverse primer sequence was 5'-AG CTC AAT TTT CTC CTC CTT GGC CTC-3', complementary to nucleotides 2673-2698 and is close but downstream from the endogenous unique EcoRI site (the superscript number in the oligonucleotide sequence indicates the corresponding position in the rabbit cardiac alpha 1C sequence) (48). The amplified fragments were used to replace the corresponding fragment in alpha 1C-SB DNA. The net result was the deletion from the second amino acid residue through the number indicated in the name of construct.

DNAs of alpha 1C fragments designed to create glutathione S-transferase (GST) fusion proteins were constructed using a similar PCR strategy, with primers containing the desired restriction sites. These fragments were cloned into pGEX-4T-1 (Amersham Pharmacia Biotech). The N-terminal cDNA fragment (N, encoding a.a. 1-154) and three C-terminal cDNA fragments (C, encoding a.a. 1505-2171, C1, encoding a.a. 1664-1845, and C2, encoding a.a. 1821-2171) were inserted into EcoRI and NotI restriction sites of pGEX-4T-1. GST-LI-II, encoding a.a. 438-550, was inserted into EcoRI and XhoI sites of pGEX-4T-1. The C1 fragment was additionally subcloned into pGEM-HE vector at the same restriction sites, and two more N-terminal fragments, N1-139 and N88-139, were created by a similar PCR procedure and also inserted into pGEM-HE between EcoRI and HindIII for in vitro transcription and expression in oocytes. All PCR products were sequenced at the Tel Aviv University Sequencing Facility. Capped mRNAs were synthesized in vitro using the suitable RNA polymerases, as described (49). When WT and one of the mutant channels have been compared in electrophysiological experiments, care was taken always to use RNAs derived from the same cDNA vector. Materials and enzymes for molecular biology were purchased from Boehringer-Mannheim, Promega, or MBI Fermentas.

Oocyte Culture and Electrophysiology-- Xenopus laevis frogs were maintained and operated, and oocytes were collected, defolliculated, and injected with RNA as described (49, 50). In each experiment, oocytes were injected with equal amounts (by weight) of the mRNAs of the various channel subunits in the desired combinations and with RNAs of additional proteins as detailed in the figure legends. Oocytes were incubated at 20-22 °C in ND96 solution (96 mM NaCl, 2 mM KCl, 1 mM MgCl2, 5 mM HEPES, pH 7.5) supplemented with 1 mM CaCl2, 2.5 mM sodium pyruvate, and 50 µg/ml gentamycin. For patch clamp experiments, the vitelline membrane was removed with fine forceps after ~5 min incubation in the bathing solution, as described (49). Whole cell currents were recorded using two-electrode voltage clamp as described (45), in a solution containing 40 mM Ba(OH)2, 50 mM NaOH, 2 mM KOH, and 5 mM HEPES, titrated to pH 7.5 with methanesulfonic acid. Usually, the concentrations of alpha 1C RNA of WT and N-terminal deletion mutants were not equal but chosen in such a way that the amplitudes of the expressed currents were below 3 µA, to avoid artifacts introduced by series resistance and by Ba2+-activated Cl- currents when larger currents are measured (51). Net Ba2+ currents were obtained by a standard leak subtraction procedure or, when alpha 1C subunit alone was expressed, by subtraction of currents measured after inhibiting all Ca2+ channel currents by 100 µM Cd2+. Absence of contribution of the endogenous currents of the oocyte was verified by inhibiting IBa with 10 µM nifedipine. Single channel recordings were done in the cell-attached mode as described (50), using Axopatch 200 amplifier (Axon Instruments, Foster City, CA). Pipettes contained 110 mM BaCl2, 10 mM HEPES/NaOH, pH 7.5. The oocytes were bathed in a solution containing 130 mM KCl, 1 mM MgCl2, 10 mM HEPES/KOH, pH 7.5. Currents were filtered at 2 kHz (4-pole Bessel) and sampled at 10 or 5 kHz. Voltage steps from -80 to 10 mV lasting 140 or 280 ms were delivered every 1 or 2 s. Leak and capacitative currents were subtracted from the traces using blank sweeps during the analysis session. Data acquisition and analysis were done with pCLAMP (Axon Instruments, Foster City, CA).

Immunochemistry-- This was performed as described (50, 52). Oocytes were injected with mRNAs and incubated in NDE solution containing 0.5 mCi/ml [35S]methionine/cysteine (Amersham Pharmacia Biotech) for 3-4 days at 22 °C. Plasma membranes together with the vitelline membranes (extracellular collagen-like matrix) were removed manually with fine forceps after a 5-15-min incubation in a low osmolarity solution. The remainder of the cell (internal fraction) was processed separately. 10-30 plasma membranes and 10 internal fractions were solubilized in 100 µl of buffer (4% SDS, 10 mM EDTA, 50 mM Tris, pH 7.5, 1 mM phenylmethanesulfonyl fluoride, 1 mM pepstatin, and 1 mM 1,10-phenanthroline) and heated to 100 °C for 2 min. Following the addition of 100 µl of H2O and 800 µl of the immunoprecipitation buffer (190 mM NaCl, 6 mM EDTA, 50 mM Tris, pH 7.5, and 2.5% Triton X-100), homogenates were centrifuged for 10 min at 1000 × g at 4 °C. The supernatant was incubated for 16 h with the Card-I polyclonal antibody (53), incubated for 1 h at 4 °C with protein A-Sepharose, and pelleted. Immunoprecipitates were washed 3 times with immunowash buffer (150 mM NaCl, 6 mM EDTA, 50 mM Tris-HCl, pH 7.5, 0.1% Triton X-100, and 0.02% SDS). Samples were boiled in SDS-gel loading buffer and electrophoresed on 3-8% SDS-polyacrylamide gradient gel together with standard molecular mass markers (45-205 kDa). Gels were dried and placed in PhosphorImager (Molecular Dynamics) cassette for up to 3 days. The protein bands of the image were estimated quantitatively using the software ImageQuant, as described (50, 54).

Binding of the GST Fusion Proteins to 35S-Labeled Proteins-- This was done essentially as described (21). [35S]Met/Cys-labeled beta 2A was translated on the template of in vitro synthesized RNA using a translation rabbit reticulocyte kit (Promega) according to manufacturer's instructions. The fusion proteins were synthesized and extracted from Escherichia coli according to pGEX-4T-1 manufacturer's instructions (Amersham Pharmacia Biotech). The protein concentration was estimated using the Bio-Rad protein assay kit (Munchen, Germany). Purified GST fusion proteins (5-10 µg) or purified GST (~10 µg) were incubated with 5 µl of the lysate containing the 35S-labeled beta 2A in 500 µl of phosphate-buffered saline with 0.05% Tween 20, for 2 h at room temperature, with gentle rocking. Then the GST fusion protein was immobilized on glutathione-Sepharose beads (Amersham Pharmacia Biotech; 30-µl beads were added) for 30 min at 4 °C and washed four times in 1 ml of phosphate-buffered saline with 0.05% Tween 20. (In some experiments, the 35S-labeled proteins were incubated with GST fusion proteins already immobilized on the glutathione-Sepharose beads.) Following washing, GST fusion proteins were eluted with 20 mM reduced glutathione in elution buffer (120 mM NaCl, 100 mM Tris-HCl, pH 8, 30 µl) and analyzed by SDS-PAGE.

Data Presentation and Statistical Analysis-- The results are always presented as means ± S.E. Multiple group comparisons have been done by one-way analysis of variance test followed by Dunnett's test. Two-group comparisons were done using Student's t test.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

N-terminal Deletions Increase Ca2+ Channel Current but Not Protein Expression-- To study the role of the first 46 amino acids of the N terminus, we created a deletion mutant of alpha 1C in which these amino acids, except the initial methionine, have been deleted (alpha 1CDelta N2-46; see Fig. 6 for a scheme of the channel to help localize the deletions). Ba2+ currents via the expressed Ca2+ channels were measured using the two-electrode voltage clamp technique. The subunit composition of the channels used in this study was varied according to the specific questions asked. The expression of wild-type (WT) alpha 1C subunit alone was rarely employed because it resulted in very small currents, usually below 20 nA (cf. Ref. 45). In most cases, alpha 1alpha 2delta combination was used, because the beta  subunit was found to interfere or interact with the modulatory effects of N-terminal deletions and of PKC (see below).

In agreement with Wei et al. (1), the whole cell Ca2+ channel currents carried by Ba2+ (IBa) via channels containing the mutant alpha 1CDelta N2-46 subunit were 5-10-fold larger than with the wild-type alpha 1C in all subunit combinations tested as follows: alpha 1C alone, alpha 1alpha 2delta , or alpha 1alpha 2delta beta (e.g. Fig. 1A). Even when the oocytes were injected with twice as much WT alpha 1C RNA, the Delta N2-46 mutant still gave ~4-fold larger currents (Fig. 1B). The kinetics of the current (Fig. 1A; see also Figs. 3 and 5) and the voltage dependence of activation were not altered; the latter is demonstrated by the similarity of the normalized current-voltage (I-V) curves (Fig. 1C). An additional deletion mutant missing most of the N terminus, alpha 1CDelta N2-139, increased the current about ~10-fold compared with WT (Fig. 1D) and did not shift the I-V curve (data not shown). However, we noticed differences in voltage-dependent inactivation of alpha 1CDelta N2-139 and the WT channels. In the alpha 1alpha 2delta composition, when compared with the WT, the steady-state inactivation curve of the mutant was shifted to more positive potentials; the slope of the curve was increased, and the proportion of non-inactivating current was reduced (Fig. 1E). Coexpression of beta 2A subunit shifted the inactivation curve of the WT type channel to negative potentials and increased the slope (compare data shown by solid circles in Fig. 1, E and F), as reported previously (45, 55, 56). In the full subunit composition, the deletion of the 139-a.a. again caused a decrease in the non-inactivating fraction and an increase in the slope. However, unlike in the alpha 1 alpha 2delta channels, in the alpha 1alpha 2delta beta channels the 139-a.a. deletion caused a leftward shift in the curve. The inactivation kinetics were unaffected. With 3-min long depolarizing pulses to +30 mV, after an initial decay the alpha 1alpha 2/delta channels' current reached a steady-state level (after ~2.4 min) of 61 ± 2% of peak in WT (n = 10) and 57 ± 3% of peak in Delta N2-139. Although the functional significance of the changes in voltage dependence of inactivation is unclear, they indicate that the deletion of N-terminal amino acids may affect gating of the channel. Since the presence of the beta  subunit modified the effect of the N-terminal deletion, a cross-talk between N terminus and the beta subunit is possible.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 1.   Effects of N-terminal deletions on whole cell Ca2+ channel current and on voltage dependence of activation and steady state inactivation of IBa. A, Ca2+ channel currents from representative X. laevis oocytes of one batch, injected with RNAs of alpha 1C of WT or Delta N2-46 deletion mutant, in combination with alpha 2delta subunit. Currents were elicited by test pulses to +20 mV from a holding potential of -80 mV. B, mean currents of in groups of oocytes injected as explained in A, obtained from three batches of oocytes. 5 ng of alpha 1CWT and 2.5 ng of alpha 1CDelta N2-46 cRNAs were injected per oocyte, with an equal amount of alpha 2delta RNA. Currents were measured 6-8 days after RNA injection. Numbers above bars indicate the number of cells assayed; numbers in parentheses indicate the number of donors (oocyte batches). C, normalized I-V curves recorded in oocytes of one batch. Currents elicited at each test potential were normalized to the maximal amplitude in the same oocyte. Averaged currents (mean ± S.E.) are plotted as a function of test potential. alpha 1CWT + alpha 2delta , open circle , n = 5; alpha 1CDelta N2-46+ alpha 2delta , square , n = 6. D, Ca2+ channel currents measured 3 days after the injection of equal amounts (2.5 ng per oocyte) of cRNAs of alpha 1CWT or alpha 1CDelta N2-139, in combination with alpha 2delta . E and F, averaged steady-state inactivation curves in alpha 1alpha 2delta (E) or alpha 1alpha 2delta beta (F) channels containing either WT (bullet ) or Delta N2-139 (open circle ) alpha 1C. The currents were examined with two-pulse protocol as follows: a 3-s prepulse to different voltages (starting from -80 mV, with 10 mV increments) followed by a test pulse to +20 mV. Data were obtained from two different batches of oocytes including at least five cells in each group. Results are represented as means ± S.E. The averaged data were fitted to the Bolzmann equation: IBa/Imax = f + 1/{1 + exp((Vprepulse - V1/2)/Ki)}, where Imax is the current obtained by the step from -80 to 20 mV, V1/2 is the half-inactivation voltage, Ki is a slope factor, and f is the non-inactivating fraction. The solid lines were drawn with the following values (WT is given first, Delta N2-139 second): in E, Ki was 19.6 mV in WT and 17 mV in Delta N2-139; V1/2, 19 and 38 mV; f, 0.45 and 0.33; in F, Ki was 15.9 mV in WT and 13.2 mV in Delta N2-139; V1/2, 6 and -3.6 mV; f, 0.47 and 0.38.

The increase in whole cell Ca2+ channel currents by the N-terminal deletions might be due to an increase in the amount of alpha 1C protein in the plasma membrane. Xenopus oocytes present a convenient experimental system to examine this question, since a very clean preparation of the plasma membrane can be obtained by mechanical separation from the rest of the cell ("internal fraction," Refs. 52 and 57). Newly synthesized proteins are metabolically labeled with 35S by incubating the oocytes in [35S]methionine/cysteine for 3-4 days following the RNA injection, immunoprecipitated, and subjected to SDS-PAGE, and the relative amount of protein is quantified using an imaging procedure (50, 52). This allows high precision measurements of changes in the content of protein in whole oocytes and in plasma membrane (50, 52, 54).

The channels were expressed in the alpha 1alpha 2delta composition. alpha 1 subunit was immunoprecipitated (50) with the Card-I antibody directed against part of the II-III linker (53) and analyzed as explained above. Fig. 2A illustrates the results of a representative experiment that demonstrated comparable expression of channels containing either WT or Delta N2-46 alpha 1C in the internal fraction (right panel, lanes 2 and 3) and in the plasma membrane (Fig. 2A, left panel, compare lanes 5 and 6). Oocytes uninjected with RNA gave no signal (Fig. 2A, lanes 1 and 4). Fig. 2B summarizes the results of the quantitative analysis of the experiments in all three oocyte batches tested. It can be seen that the total cellular amount of Delta N2-46 alpha 1C was only about half that of the WT, whereas the amounts of WT and Delta N2-46 alpha 1C in the plasma membrane were roughly equal (the ~30% reduction in the mutant protein was not statistically significant). These data suggest that the vast increase in the whole cell Ca2+ channel current caused by the 46-a.a. deletion is not caused by an increase in the level of expression of the channel protein.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 2.   Comparison of the expression level of the WT and Delta N2-46 alpha 1C protein in plasma membrane and internal fractions of Xenopus oocytes. A, digitized PhosphorImager scan of SDS-PAGE analysis of the alpha 1C and alpha 1CDelta N2-46 proteins (coexpressed with alpha 2delta subunit) in oocytes metabolically labeled with [35S]Met/Cys. Radiolabeled proteins were immunoprecipitated from plasma membranes (lanes 1-3) and internal fractions (lanes 4-6) separately. In each lane, immunoprecipitates from 30 plasma membranes and 10 internal fractions were loaded. Lanes 1 and 4 represent immunoprecipitates from native oocytes that have not been injected with cRNAs. B, relative amounts of the alpha 1CDelta N2-46 detected in plasma membrane and internal fraction, calculated as percent of the expressed alpha 1CWT protein in the same batch of oocytes, recalculated per single oocyte. Total protein is the sum of both fractions. Band intensities were measured using PhosphorImager. Data were averaged from three different batches of oocytes and presented as means ± S.E.

The N-terminal Deletions Modify Channel Gating-- If the N-terminal deletion does not alter the amount of channels in the plasma membrane, then the increase in whole cell current must result from an increase in the activity of each channel (which can be measured using the patch clamp technique). In other words, the open probability of a single channel must be higher in Delta N2-46 alpha 1C than in the WT alpha 1C, whereas the number of channels in patches of similar sizes must be comparable. To address this question, an accurate estimate of the amount of channels in the patch (N) is imperative (58). Unfortunately, Po of the L-type channels is low (<1%), making such estimate extremely difficult. However, Po increases substantially in the presence of dihydropyridine agonists such as (-)-BayK 8644 (reviewed in Ref. 8). In Xenopus oocytes expressing L-type Ca2+ channels, in the presence of this drug, N can be reliably estimated from the number of overlapping openings in a long series of depolarizing voltage steps, provided that N <3 (50, 59). Before recording single channel activity, we have verified that (-)-BayK 8644 increases the whole cell IBa via WT and Delta N2-46 channels by the same factor at all voltages (Fig. 3. To avoid possible series resistance errors, the amounts of WT and mutant RNAs were adjusted to produce currents of similar amplitudes.). Thus, in the presence of (-)-BayK 8644, the differences between the WT and Delta N2-46 channels appear to be preserved.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 3.   (-)-BayK 8644-induced enhancement of IBa in oocytes expressing WT or Delta N2-46 alpha 1C in combination with alpha 2delta . In the control group, WT alpha 1C and alpha 2/delta RNAs were injected at 2.5 ng/oocyte; in the test group, alpha 1C Delta N2-46 and alpha 2/delta RNAs were injected at 0.5 ng/oocyte. A and B show the typical effect of (-)-BayK 8644 on the currents elicited by depolarization step from -80 mV to +10 mV. C summarizes the increase in IBa induced by application of 1 µM (-)-BayK 8644 at different voltages. Data were averaged from three batches of oocytes (n >15 in all groups). bullet , WT; square , Delta N2-46.

Single channel recordings were performed in cell-attached configuration with 110 mM Ba2+ in the pipette, and in the presence of 1 or 2 µM (-)-BayK 8644 in the bath. Ca2+ channels (alpha 1alpha 2delta composition) were activated by depolarizing pulses from -80 to +10 mV. Our first observation was a similarity of the number of channels in membrane patches in oocytes expressing WT or Delta N2-46 alpha 1C. For instance, with 0.6 or 1.2 ng of RNA of each subunit per oocyte, and with pipettes of similar resistances (3.5-4.5 megaohms), the average number of channels in a patch was 1.3 ± 0.5 (n = 11) in WT and 1.1 ± 0.3 (n = 21) in Delta N2-46 alpha 1alpha 2delta channels.

Fig. 4A exemplifies records of channel activity in oocytes expressing WT or Delta N2-46 channels (n = 2 in both cases). It appears that the mutant channels spend more time in the open state than the WT ones. Indeed, as shown in Fig. 4B, Po was ~10-fold higher for the Delta N2-46 channels (WT, 10 patches; Delta N2-46, 8 patches; p < 0.01). Open time distribution was fitted by two exponents with time constants (tau 1 and tau 2) of about 0.4 and 2 ms for both channel types (Fig. 4, C and D, and Table I), but the fraction of time contributed by the longer openings (f2) was significantly higher in the Delta N2-46 than in WT channels (Table I). The increase in the proportion of long open times may at least partially account for the total increase in Po caused by the N-terminal deletion. By visual examination, another prominent difference was the prevalence of very long bursts of channel activity in the mutant channels; such bursts were rare in the WT channels. A rigorous burst analysis will require one-channel recordings which were rare in this study. Whatever the main factor contributing to the increase in Po, it is evident that the N-terminal 46-a.a. deletion causes a major change in the gating properties of the cardiac L-type Ca2+ channel, at least in the presence of (-)-BayK 8644. However, we must add a reservation: in a few oocytes where Po was measured both before and after the addition of (-)-BayK 8644, the increase in Po was much stronger than in whole cell recordings, ranging from 5- to 180-fold. The reason for this phenomenon is unknown, but it warrants caution in extrapolating the findings obtained in the presence of this drug to the characteristics of naïve channels.


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 4.   Comparison of the single channel behavior of WT and Delta N2-46 alpha 1C (coexpressed with alpha 2delta ) in presence of 1 µM (-)-BayK 8644. A, representative consecutive traces of WT and mutant channel activity at 10 mV. B, averaged Po from 10 patches for WT and 8 patches for Delta N2-46 channels. C and D, typical open time histograms. For each of the channels, both brief and long open events were present. The smooth curves represent best fits with two exponentials. The values of the time constants (tau 1 and tau 2) and the fractions of total open time spent in each of the open states (f1 and f2) are shown in the insets.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Parameters of single channel activity of WT and Delta N2-46 alpha 1Calpha 2 channels
To calculate Po (the single channel open probability), the number of channels was determined from the maximal number of overlapping openings. Only patches with no more than three channels have been analyzed. Open time histograms of the first level openings were fitted with two exponents. tau 1 and tau 2 are the short and the long time constants, and f1 and f2 are the fraction of total open time contributed by openings corresponding to tau 1 or tau 2, respectively.

To account for the above observations and for the finding that removal of proximal N terminus increases gating charge movement (1), we put forward a working hypothesis: the N terminus hinders activation (e.g. by obstructing the movement of the voltage sensor), therefore its deletion improves activation. It is notable that coexpression of the beta  subunit also improves activation and alters gating charge movement (60, 61), although the details differ (see "Discussion"). Therefore, we assumed that the N terminus and the beta  subunit may affect a common mechanism and thus they may interact with each other (as also suggested by the changes in voltage-dependent inactivation; see above). This was tested by studying the effect of coexpression of the beta  subunit with channels containing either WT or one of the deletion mutants of alpha 1C (Delta N2-46 or Delta N2-139). Coexpression of beta 2A with alpha 1alpha 2delta increased the whole cell IBa both in WT (Fig. 5A, a) and in Delta N2-139 (Fig. 5A, b), but the increase caused by coexpression of beta 2A was significantly (p < 0.01) smaller in Delta N2-139 than in WT, at all voltages (Fig. 5B). The results with Delta N2-46 were similar (in this case, we tested the effect of coexpression of beta 2A on channels composed of alpha 1C alone).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 5.   The effect of coexpression of the beta 2A subunit on the amplitude of currents via channels containing alpha 1C of WT, Delta N2-139, and Delta N2-46 type. A, currents recorded in representative oocytes of one batch by depolarization from -80 to 20 mV. The oocytes were injected with the subunit combinations indicated near the traces. a, RNAs of all subunits were injected at 2.5 ng/oocyte. b, RNAs of all subunits were injected at 1 ng/oocyte. B, summary of the effects of beta 2A coexpression on channels containing WT (open circle ) and Delta N2-139 (square ) alpha 1C (2 batches; 10 oocytes in each group). In all groups, alpha 2delta was also expressed. In each oocyte IBa was expressed as percent of the mean amplitude of the current in the control group of oocytes from the same donor. These normalized values were averaged across all oocyte batches tested. Data are shown as mean ± S.E. C, summary of the effects of beta 2A coexpression on channels with WT (bullet ) and Delta N2-46 (black-square) alpha 1C (two batches; n = 18 in each group). In these experiments, alpha 2delta was not expressed; thus, channels composed of alpha 1 alone versus alpha 1beta were tested. Averaging of data was done as explained in B.

To probe for a possible physical interaction between the beta  subunit and the N terminus of alpha 1C, we have measured in vitro binding of GST fusion proteins corresponding to some of the intracellular parts of alpha 1C, to beta 2A synthesized in reticulocyte lysate and labeled with [35S]methionine/cysteine (see Ref. 20). The following GST fusion proteins were used: GST-N, corresponding to amino acids (a.a.) 1-154, i.e. the whole-length N terminus; GST-LI-II, corresponding to most of the intracellular linker between domains I and II (a.a. 438-550); and GST-C1 (a.a. 1664-1845) and GST-C2 (a.a. 1821-2171), corresponding to two parts of the C terminus. The scheme of the alpha 1C subunit in Fig. 6A illustrates the positions of the different pieces. As expected (20, 21), beta 2A bound to GST-LI-II, but we could not detect binding to any one of the other fusion proteins tested (Fig. 6B). (Note that the amounts of all GST fusion proteins loaded on the gel were similar, as demonstrated in Fig. 6C.)


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 6.   Interaction of in vitro synthesized beta 2A with GST fusion proteins of alpha 1C fragments. A, schematic presentation of the alpha 1C subunit of the L-type Ca2+ channel (rabbit heart isoform numbering). B, interaction of beta 2A with GST fusion proteins corresponding to parts of alpha 1C. The proteins were separated by SDS-15% PAGE and monitored using PhosphorImager. N denotes GST-N (the whole N terminus); L denotes GST-LI-II (a.a. 438-550); C2 denotes GST-C2 (a.a. 1821-2171(end); C1 denotes GST-C1 (a.a. 1664-1845). Similar results were obtained in two additional experiments. C, Coomassie Blue staining of the gel shown in B. Arrowheads indicate the predicted positions of the fusion proteins.

If the N terminus obstructs activation, then artificial proteins corresponding to fragments of N terminus may be expected to reduce IBa. We constructed DNAs encoding proteins corresponding to N-terminal a.a. 1-139 of alpha 1C (N1-139), N-terminal a.a. 88-139 (N88-139), and C-terminal a.a. 1664-1845 (C1664-1845; denoted as C in Fig. 7). The corresponding RNAs directed the expression of proteins of correct size in reticulocyte lysate (data not shown). Coexpression of RNAs encoding N1-138 and N88-139 proteins with channels containing a truncated alpha 1C (either Delta N2-46 or Delta N2-139) reduced IBa, whereas C1665-1845 was without effect (Fig. 7). The reduction was stronger when the channels contained the Delta N2-139 truncation than Delta N2-46, possibly because in the Delta N2-46 alpha 1C the presence of the remaining part of N terminus hindered the access of the exogenous proteins to a target site.


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 7.   Inhibitory effect of coexpression of N-terminal fragments on IBa via channels containing Delta N2-139 (A) or Delta N2-46 alpha 1C (B). Top, summaries of all experiments with Delta N2-139 (A, a) and Delta N2-46 (B, a). Channels were expressed in the alpha 1alpha 2delta composition, without (control) or with the addition of RNA of the desired fragment, as indicated below the bars. In each oocyte, IBa was expressed as percent of the mean amplitude of the current in the control group of oocytes from the same donor. These normalized values were averaged across all oocyte batches tested. Data represent the means ± S.E. Numbers above bars indicate the number of cells assayed, and numbers in parentheses indicate the number of donors (oocyte batches). The decrease in IBa caused by both N-terminal fragments tested was statistically significant in all cases (p < 0.05). Bottom, normalized I-V curves recorded in the oocytes of the same groups. open circle , control; black-square, N1-139; black-triangle, N88-139; black-down-triangle , C.

The First 46 Amino Acids Are Essential for PKC-induced Increase in IBa-- Fig. 8A shows diaries of representative experiments in which the PKC activator, PMA, was added to the extracellular solution at t = 0. In agreement with our previous report (39), PMA caused a biphasic change in IBa, an increase within several minutes was followed by a later decrease; the increase was stronger in alpha 1alpha 2delta channels than in any combination containing beta 2A. Fig. 8B summarizes the measurements done in two oocyte batches in which we examined the differences in response to PMA among channels of alpha 1alpha 2delta , alpha 1beta , and alpha 1alpha 2delta beta composition (increase in IBa 15 min after PMA addition is shown). Clearly, coexpression of beta 2A significantly reduced the extent of current potentiation caused by PMA.


View larger version (50K):
[in this window]
[in a new window]
 
Fig. 8.   Importance of the beta  subunit and of the unique N-terminal part of alpha 1C in modulation of the channel activity by beta -PMA-induced stimulation of PKC. A, changes in IBa induced by 10 nM beta -PMA as a function of the time in representative oocytes injected with the indicated RNAs. 200-ms test pulses from a holding potential of -80 mV to a test potential of +20 mV were applied every 30 s. Peak current amplitudes were normalized to the current in control conditions, whose stabilization was verified for at least 5 min before PMA application. B, attenuation of the beta -PMA effect by coexpressed beta 2A subunit. The right bar shows the effect of beta -PMA on channels containing the alpha 1C(st1665) truncation mutant. In each oocyte, IBa was expressed as percent of the current amplitude before application of beta -PMA. These normalized values were averaged across all oocytes in the batches tested. Numbers above bars indicate the number of cells assayed, and numbers in parentheses indicate the number of batches. Asterisks indicate statistically significant difference (p < 0.05) from WT alpha 1alpha 2delta , obtained by two-tailed t-test. C, summary of the effects of beta -PMA on different alpha 1 mutants compared with the WT. The bar denoted neuronal corresponds to the neuronal rbC-II alpha 1C isoform. Data analysis and presentation as in B. Asterisks indicate statistically significant difference (p < 0.05) from WT examined in the same batches of oocytes. D, alignment of the N-terminal sequences of three isoforms of L-type Ca2+ channel alpha 1C subunits (see definitions in the text). Asterisks indicate identity in all three sequences, x indicates identity in two out of three sequences.

The C terminus of alpha 1C contains a large number of putative PKC and protein kinase A phosphorylation sites. To examine whether these sites play a role in PKC modulation, we expressed channels based on a truncation mutant, alpha 1C(st1665), in which part of the C terminus beyond a.a. 1665 is missing (16). Full subunit combination, alpha 1alpha 2delta beta , was tested, because the alpha 1C(st1665) mutant usually gave rather small currents when expressed without beta . Fig. 8B (right column) shows that the effect of PMA was not altered by this truncation (compare with the results obtained with WT alpha 1alpha 2delta beta ).

In the following experiments, alpha 1alpha 2delta combination was used to allow a better visualization of PMA-induced enhancement of IBa. The effects of PMA varied among oocyte batches; therefore, mutant and WT channels were always compared in the same batch(es) of oocytes. Fig. 8C summarizes the results of this series of experiments and shows that the deletion of the first 46 N-terminal amino acids completely eliminated the PMA-induced increase in IBa, leaving the reduction phase intact (a representative experiment diary is shown in Fig. 8A, triangles). A rat brain alpha 1C isoform with a variant N terminus (see below) did not show an increase in IBa in response to PMA, in agreement with a previous report (44). The PMA effect remained intact in all other mutants tested, among them alpha 1CS533I (a putative PKC site in linker I-II), alpha 1CS1575A (a C-terminal site preceding the st1665 truncation), and an N-terminal deletion Delta N88-139.

Fig. 8D compares a.a. sequences (deduced from the corresponding cDNA sequences) of the initial N-terminal segment of three most widely tested variants of alpha 1C as follows: rabbit heart alpha 1C (48) used in this study (RH); rat brain alpha 1C isoform, rbC-II (RB; Ref. 42); and a human heart isoform (HH; Ref. 43). The latter two isoforms are not up-regulated by PKC activators, and their N termini vary from that of the RH alpha 1C. N termini of two additional isoforms cloned from lung (62) and rat brain (rbC-I; Ref. 42) are identical to that of RB in Fig. 8D. N termini of all isoforms are essentially identical beyond a.a. 46 (numbering by RH alpha 1C). A closer examination shows that there is an additional region between a.a. 6 and 20, in which RB and HH are identical to each other and also show significant homology (33% identity) to RH alpha 1C. The correlation between PMA effects (or their absence) and the primary structure of the initial alpha 1C N-terminal segments of these isoforms supports the idea that the unique initial 46 amino acids of RH alpha 1C are essential for PKC modulation.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

N Terminus Modulates L-type Channel Gating-- Our results demonstrate the functional importance of the N terminus of alpha 1C subunit in L-type Ca2+ channel function and modulation. Deletion of the initial 46 amino acids of the N terminus, which are unique to rabbit heart isoform, increases the whole cell Ca2+ channel current (see also Ref. 1) but does not increase the expression of the channel, as testified by the unchanged plasma membrane content of alpha 1C protein monitored by an immunochemical method, and similar density of functional channels detected by patch clamp methodology. Our data strongly suggest that this deletion alters the gating of the channel. First of all, it enhances the activity of single Ca2+ channels as testified by the ~10-fold increase in Po. This change in channel gating alone is sufficient to account for the increase in whole cell Ca2+ channel current caused by this and probably by the other deletions tested (a.a. 2-139). An alteration of channel gating by the N terminus is further supported by differences in voltage dependence of inactivation in WT and Delta N2-139 channels, and by a decrease in whole cell current amplitude by coexpression of proteins corresponding to N-terminal a.a. 1-139 or 88-139, but not by a C-terminal protein. The results of the latter experiments imply that, in addition to the first 46 amino acids, other parts of the N terminus participate in its effect; however, a more detailed study will be necessary to scrutinize this hypothesis. We propose that, in L-type channels containing the rabbit heart isoform of alpha 1C, the N terminus imposes a tonic inhibitory control which is relieved in the truncation mutants tested. This mechanism is, to some extent, similar to that proposed to explain the increase in Ca2+ channel current caused by C-terminal deletions and by protein kinase A phosphorylation (12, 13).

In expression studies, changes in total gating charge movement (Qmax) caused by coexpression of Ca2+ channels beta  or alpha 2delta subunits (60, 61, 63, 64) usually correlate well with the amount of alpha 1C protein detected in the membrane by immunochemical methods (50). How can our results be accommodated with the fact that deletions of initial 40-120 a.a. of alpha 1C increase Qmax without changing its voltage dependence (1)? We claim that, in general, a change in Qmax does not necessarily report a change in the number of functional channels. In various voltage-dependent channels, Qmax can be altered by drugs, toxins, or by fatty acids. For instance, Qmax in Na+ channels is decreased by Anthopleurin-A toxin (65), fatty acids (66), and lidocaine (67); in L-type Ca2+ channels, Qmax is decreased by dihydropyridines (68, 69). Thus, the N terminus might decrease Qmax by directly or allosterically interfering with the movement of the voltage sensor of the channel; removal of the N terminus would increase Qmax.

beta Subunit and PKC Interact with the N Terminus-- Our data suggest a cross-talk between the N terminus of alpha 1C and the beta 2A subunit. It appears that the presence of the beta  subunit attenuates the inhibitory effect of the N terminus. This is supported by the following observations. (i) Coexpression of beta 2A enhances the whole cell currents more efficiently when the N terminus is intact than when a.a. 1-46 or 1-139 are removed. It is possible that part of the beta -induced channel enhancement is due to a weakening of the inhibitory effect of the N terminus; this explains why, in the absence of the latter, the augmentation caused by beta  subunit is less pronounced. (ii) beta  subunit counteracts the effect of PKC which is mediated via an interaction with the N terminus (see below). A cross-talk between beta 2A and the N terminus of alpha 1C is also supported by the observation that Delta N2-139 deletion-induced changes in voltage-dependent inactivation properties are different in the absence and presence of beta 2A. The interaction does not appear to be a direct one, since beta 2A does not bind a GST fusion protein of the first 154 a.a. (Of the GST fusion proteins tested, the only beta 2A-binding protein was that of the I-II domain linker, which contains a beta 2A-binding site conserved in all known alpha 1 subunits (20, 21, 70, 71); the results of Fig. 6 suggest that, unlike alpha 1E (71), alpha 1C does not seem to have a C-terminal beta  subunit binding site.) Thus, beta  subunit interacts with the N terminus allosterically ("at distance"). The mechanism is unclear and seems to involve the voltage sensing machinery. It would be an oversimplification to assume that the action of beta  subunit is mechanistically analogous to removal of the N terminus, because of the differences in the effects of beta -coexpression and of N-terminal deletions on charge movement; the former alters the voltage dependence of current activation without changing Qmax, and the latter increases Qmax (60, 61, 70). In this respect, the enhancement of channel activity by C- and N-terminal deletions is also mechanistically different, since C-terminal truncations do not affect Qmax and have been proposed to improve the coupling between voltage sensor movement and pore opening (12).

We have identified the initial 46 a.a. of the alpha 1C as a site indispensable for the potentiating action of PKC on the channel, since the removal of this segment fully eliminates the current increase caused by PKC activation. The decrease caused by PMA must be mediated by an action on another site. It is not clear whether the enhancing effect of PKC is caused by a direct phosphorylation of one of the amino acid residues in this region of the channel. Theoretically, phosphorylation may occur on another part of alpha 1C or even at an unknown protein (present in the oocytes) that modulates the channel via an interaction with the N terminus. Identification of the site of phosphorylation remains an important challenge for the future.

The biophysical mechanism by which PKC enhances the activity of the channel is unknown; one possibility is that it weakens the inhibitory control exerted by the N terminus. This assumption is in line with the observation that the PKC-induced increase in open probability of the channel is accompanied by an increase in the proportion of long openings (30, 36), like the N-terminal deletion (Table I). It is also compatible with the fact that PKC-elicited increase in Ca2+ channel current is attenuated by the beta  subunit; according to our hypothesis, the inhibition imposed by the N terminus is already weakened when beta  is present, and there is less room for a further improvement of channel activity (an occlusion mechanism). A cross-talk between the beta  subunit and PKC has also been proposed for the neuronal alpha 1B (N-type) channels (44, 72). However, the details of the proposed interaction differ significantly; in the N-type channel, PKC phosphorylates the I-II domain linker and thus counteracts an inhibitory effect of the G protein beta gamma subunit (Gbeta gamma ) which binds to the same loop; the Ca2+ channel beta  subunit also binds to the same loop, reducing the inhibition caused by Gbeta gamma and thus occluding the PKC effect (72). In the L-type channel, no modulation by Gbeta gamma has been reported; I-II linker is the site of beta  subunit binding but it is not phosphorylated by PKC2; beta  appears to interact with the PKC target site allosterically rather than sterically.

alpha 1C Subunits with Rabbit Heart-type N Terminus Should Be Widespread-- Alternative splicing products of alpha 1C are found in various tissues; they have been proposed to play an important role in generating a diversity of electrophysiological properties (14, 42, 62, 73, 75). Alternative splicing was also proposed to take place in the N terminus, and "rabbit heart," "rat brain," and "lung" cDNAs have been assumed to be splice variants of the same gene product (42, 62). Recently, the genomic structure of human L-type Ca2+ channel has been characterized and shown to contain at least 44 invariant and 6 alternative exons (74). The unique stretch between Ser21 and Gly47 present in rabbit heart isoform (RH alpha 1C numbering; Fig. 8D) appears to be missing from the human genomic alpha 1C RNA (74), casting doubt on the biological relevance of the isoform cloned from rabbit heart. In fact, however, the details of splicing at the beginning of the human alpha 1C N terminus are unclear. The incomplete sequencing of putative intron 1 that separates between exon 1 ending with Gln16 (alpha 1C HH numbering; Fig. 8D) and exon 2 starting with Gly17 (corresponds to Gly47 of rabbit heart alpha 1C) left open the possibility of an additional exon(s) in this region (74). In view of the commonality of PKC-induced enhancement of Ca2+ channel activity in heart and smooth muscle cells of many mammalian species, it is probable that an additional variable exon encoding an N-terminal sequence similar or identical to the rabbit heart isoform may exist. The presence of an isoform containing this sequence in a particular cell type may be predictive of an enhancing PKC effect, and vice versa.

    ACKNOWLEDGEMENTS

We thank I. Lotan for many discussions and for a critical reading of the manuscript; M. Hosey for the gift of the Card-I antibody; and T. P. Snutch for the gift of the rbC-II cDNA.

    FOOTNOTES

* This work was supported in part by the Israel Ministry of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 972 3 640 9863; Fax: 972 3 640 9113; E-mail: dascaln{at}post.tau.ac.il.

1 The abbreviations used are: PKC, protein kinase C; a.a., amino acid; GST, glutathione S-transferase; IBa, Ba2+ current via the voltage-dependent Ca2+ channels; PMA, 4beta -phorbol 12-myristate 13-acetate; PAGE, polyacrylamide gel electrophoresis; WT, wild type; PCR, polymerase chain reaction.

2 T. Ivanina, E. Shistik and N. Dascal, unpublished observations.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Wei, X., Neely, A., Olcese, R., Lang, W., Stefani, E., and Birnbaumer, L. (1996) Recept. Channels 4, 205-215[Medline] [Order article via Infotrieve]
  2. Reuter, H. (1983) Nature 301, 569-574[Medline] [Order article via Infotrieve]
  3. Hughes, A. D. (1995) J. Vasc. Res. 32, 353-370[Medline] [Order article via Infotrieve]
  4. Xiong, Z., and Sperelakis, N. (1995) J. Mol. Cell. Cardiol. 27, 75-91[Medline] [Order article via Infotrieve]
  5. Hofmann, F., Biel, M., and Flockerzi, V. (1994) Annu. Rev. Neurosci. 17, 399-418[CrossRef][Medline] [Order article via Infotrieve]
  6. Snutch, T. P., and Reiner, P. B. (1992) Curr. Opin. Neurobiol. 2, 247-253[Medline] [Order article via Infotrieve]
  7. Catterall, W. A. (1993) Trends Neurosci. 12, 500-506
  8. Glossmann, H., and Striessnig, J. (1990) Rev. Physiol. Biochem. Pharmacol. 114, 1-105[Medline] [Order article via Infotrieve]
  9. Isom, L. L., De Jongh, K. S., and Catterall, W. A. (1994) Neuron 12, 1183-1194[Medline] [Order article via Infotrieve]
  10. Hosey, M. M., Chien, A. J., and Puri, T. S. (1996) Trends Cardiovasc. Med. 6, 265-273[CrossRef]
  11. Gurnett, C. A., and Campbell, K. P. (1996) J. Biol. Chem. 271, 27975-27978[Free Full Text]
  12. Wei, X., Neely, A., Lacerda, A. E., Olcese, R., Stefani, E., Perez-Reyes, E., and Birnbaumer, L. (1994) J. Biol. Chem. 269, 1635-1640[Abstract/Free Full Text]
  13. Klockner, U., Mikala, G., Varadi, M., Varadi, G., and Schwartz, A. (1995) J. Biol. Chem. 270, 17306-17310[Abstract/Free Full Text]
  14. Soldatov, N. M., Zuhlke, R. D., Bouron, A., and Reuter, H. (1997) J. Biol. Chem. 272, 3560-3566[Abstract/Free Full Text]
  15. Zhou, J. M., Olcese, R., Qin, N., Noceti, F., Birnbaumer, L., and Stefani, E. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 2301-2305[Abstract/Free Full Text]
  16. Perets, T., Blumenstein, Y., Shistik, E., Lotan, I., and Dascal, N. (1996) FEBS Lett. 384, 189-192[CrossRef][Medline] [Order article via Infotrieve]
  17. De Jongh, K. S., Murphy, B. J., Colvin, A. A., Hell, J. W., Takahashi, M., and Catterall, W. A. (1996) Biochemistry 35, 10392-10402[CrossRef][Medline] [Order article via Infotrieve]
  18. Mitterdorfer, J., Froschmayr, M., Grabner, M., Moebius, F. F., Glossmann, H., and Striessnig, J. (1996) Biochemistry 35, 9400-9406[CrossRef][Medline] [Order article via Infotrieve]
  19. Gao, T., Yatani, A., Dell'Acqua, M. L., Sako, H., Green, S. A., Dascal, N., Scott, J. D., and Hosey, M. M. (1997) Neuron 19, 185-196[Medline] [Order article via Infotrieve]
  20. Pragnell, M., De Waard, M., Mori, Y., Tanabe, T., Snutch, T. P., and Campbell, K. P. (1994) Nature 368, 67-70[CrossRef][Medline] [Order article via Infotrieve]
  21. De Waard, M., Witcher, D. R., Pragnell, M., Liu, H., and Campbell, K. P. (1995) J. Biol. Chem. 270, 12056-12064[Abstract/Free Full Text]
  22. Trautwein, W., and Hescheler, J. (1990) Annu. Rev. Physiol. 52, 257-274[CrossRef][Medline] [Order article via Infotrieve]
  23. Wickman, K., and Clapham, D. E. (1995) Physiol. Rev. 75, 865-885[Abstract/Free Full Text]
  24. Fish, R. D., Sperti, G. S., Colucci, W. S., and Clapham, D. E. (1988) Circ. Res. 62, 1049-1054[Abstract]
  25. Lacerda, A., Rampe, D., and Brown, A. M. (1988) Nature 335, 249-251[CrossRef][Medline] [Order article via Infotrieve]
  26. Dosemeci, A., Dhallan, R. S., Cohen, N. M., Lederer, W. J., and Rogers, T. B. (1988) Circ. Res. 62, 347-357[Abstract]
  27. Tseng, G. N., and Boyden, P. A. (1991) Am. J. Physiol. 261, H364-H379[Abstract/Free Full Text]
  28. Kato, H., Hayashi, T., Koshino, Y., Kutsumi, Y., Nakai, T., and Miyabo, S. (1992) Biochem. Biophys. Res. Commun. 188, 934-941[Medline] [Order article via Infotrieve]
  29. Liu, Q. Y., Karpinski, E., and Pang, P. K. (1993) Biochem. Biophys. Res. Commun. 191, 796-801[CrossRef][Medline] [Order article via Infotrieve]
  30. Schuhmann, K., and Groschner, K. (1994) FEBS Lett. 341, 208-212[CrossRef][Medline] [Order article via Infotrieve]
  31. Marinissen, M. J., Selles, J., and Boland, R. (1994) Cell. Signalling 6, 531-538[CrossRef][Medline] [Order article via Infotrieve]
  32. Zhang, S., Hirano, Y., and Hiraoka, M. (1995) Circ. Res. 76, 592-529[Abstract/Free Full Text]
  33. Chik, C. L., Li, B., Ogiwara, T., Ho, A. K., and Karpinski, E. (1996) FASEB J. 10, 1310-1317[Abstract/Free Full Text]
  34. McHugh, D., and Beech, D. J. (1997) J. Physiol. (Lond.) 500, 311-317[Abstract]
  35. Yang, J., and Tsien, R. W. (1993) Neuron 10, 127-136[Medline] [Order article via Infotrieve]
  36. Hirano, Y., Yoshinaga, T., Niidome, T., Katayama, K., and Hiraoka, M. (1996) Recept. Channels 4, 93-104[Medline] [Order article via Infotrieve]
  37. Satoh, H. (1992) Gen. Pharmacol. 23, 1097-1102[Medline] [Order article via Infotrieve]
  38. Asai, T., Shuba, L. M., Pelzer, D. J., and Mcdonald, T. F. (1996) Am. J. Physiol. 39, H620-H627
  39. Singer-Lahat, D., Gershon, E., Lotan, I., Hullin, R., Biel, M., Flockerzi, V., Hofmann, F., and Dascal, N. (1992) FEBS Lett. 306, 113-118[CrossRef][Medline] [Order article via Infotrieve]
  40. Bourinet, E., Fournier, F., Lory, P., Charnet, P., and Nargeot, J. (1992) Pfluegers Arch. 421, 247-255[Medline] [Order article via Infotrieve]
  41. Puri, T. S., Gerhardstein, B. L., Zhao, X. L., Ladner, M. B., and Hosey, M. M. (1997) Biochemistry 36, 9605-9615[CrossRef][Medline] [Order article via Infotrieve]
  42. Snutch, T. P., Tomlison, W. J., Leonard, J. P., and Gilbert, M. M. (1991) Neuron 7, 45-57[Medline] [Order article via Infotrieve]
  43. Bouron, A., Soldatov, N. M., and Reuter, H. (1995) FEBS Lett. 377, 159-162[CrossRef][Medline] [Order article via Infotrieve]
  44. Stea, A., Soong, T. W., and Snutch, T. P. (1995) Neuron 15, 929-940[Medline] [Order article via Infotrieve]
  45. Singer, D., Biel, M., Lotan, I., Flockerzi, V., Hofmann, F., and Dascal, N. (1991) Science 253, 1553-1557[Medline] [Order article via Infotrieve]
  46. Hullin, R., Singer-Lahat, D., Freichel, M., Biel, M., Dascal, N., Hofmann, F., and Flockerzi, V. (1992) EMBO J. 11, 885-890[Abstract]
  47. Liman, E. R., Tytgat, J., and Hess, P. (1992) Neuron 9, 861-871[Medline] [Order article via Infotrieve]
  48. Mikami, A., Imoto, K., Tanabe, T., Niidome, T., Mori, Y., Takeshima, H., Narumiya, S., and Numa, S. (1989) Nature 340, 230-233[CrossRef][Medline] [Order article via Infotrieve]
  49. Dascal, N., and Lotan, I. (1992) in Methods in Molecular Neurobiology (Longstaff, A., and Revest, P., eds), Vol. 13, pp. 205-225, Humana Press Inc., Totowa, NJ
  50. Shistik, E., Ivanina, T., Puri, T., Hosey, M. M., and Dascal, N. (1995) J. Physiol. (Lond.) 489, 55-62[Abstract]
  51. Singer-Lahat, D., Lotan, I., Biel, M., Flockerzi, V., Hofmann, F., and Dascal, N. (1994) Receptors Channels 2, 215-226[Medline] [Order article via Infotrieve]
  52. Ivanina, T., Perez, T., Thornhill, W. B., Levin, G., Dascal, N., and Lotan, I. (1994) Biochemistry 33, 8786-8792[Medline] [Order article via Infotrieve]
  53. Chien, A. J., Zhao, X., Shirokov, R. E., Puri, T. S., Chang, C. F., Sun, D., Rios, E., and Hosey, M. M. (1995) J. Biol. Chem. 270, 30036-30044[Abstract/Free Full Text]
  54. Levin, G., Chikvashvili, D., Singer-Lahat, D., Peretz, T., Thornhill, W. B., and Lotan, I. (1996) J. Biol. Chem. 271, 29321-29328[Abstract/Free Full Text]
  55. Wei, X., Perez-Reyes, E., Lacerda, A. E., Schuster, G., Brown, A. M., and Birnbaumer, L. (1991) J. Biol. Chem. 266, 21943-21947[Abstract/Free Full Text]
  56. Varadi, G., Lory, P., Schultz, D., Varadi, M., and Schwartz, A. (1991) Nature 352, 159-162[CrossRef][Medline] [Order article via Infotrieve]
  57. Sadler, S. E., and Maller, J. L. (1981) J. Biol. Chem. 256, 6368-6373[Free Full Text]
  58. Hille, B. (1992) Ionic Channels of Excitable Membranes, 2d Ed., Sinauer Associates, Inc., Sunderland, MA
  59. Wakamori, M., Mikala, G., Schwartz, A., and Yatani, A. (1993) Biochem. Biophys. Res. Commun. 196, 1170-1176[CrossRef][Medline] [Order article via Infotrieve]
  60. Neely, A., Wei, X., Olcese, R., Birnbaumer, L., and Stefani, E. (1993) Science 262, 575-578[Medline] [Order article via Infotrieve]
  61. Olcese, R., Neely, A., Qin, N., Wei, X. Y., Birnbaumer, L., and Stefani, E. (1996) J. Physiol. (Lond.) 497, 675-686[Abstract]
  62. Biel, M., Ruth, P., Bosse, E., Hullin, R., Stuhmer, W., Flockerzi, V., and Hofmann, F. (1990) FEBS Lett. 269, 409-412[CrossRef][Medline] [Order article via Infotrieve]
  63. Josephson, I. R., and Varadi, G. (1996) Biophys. J. 70, 1285-1293[Abstract]
  64. Bangalore, R., Mehrke, G., Gingrich, K., Hofmann, F., and Kass, R. S. (1996) Am. J. Physiol. 39, H1521-H1528
  65. Sheets, M. F., and Hanck, D. A. (1995) J. Gen. Physiol. 106, 617-640[Abstract]
  66. Bendahhou, S., Cummins, T. R., and Agnew, W. S. (1997) Am. J. Physiol. 272, C592-C600[Abstract/Free Full Text]
  67. Josephson, I. R., and Cui, Y. (1994) Pfluegers Arch. 428, 485-491[Medline] [Order article via Infotrieve]
  68. Rios, E., and Brum, G. (1987) Nature 325, 717-720[CrossRef][Medline] [Order article via Infotrieve]
  69. Hadley, R. W., and Lederer, W. J. (1992) Am. J. Physiol. 262, H472-H477[Abstract/Free Full Text]
  70. Qin, N., Platano, D., Olcese, R., Stefani, E., and Birnbaumer, L. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 8866-8871[Abstract/Free Full Text]
  71. Tareilus, E., Roux, M., Qin, N., Olcese, R., Zhou, J. M., Stefani, E., and Birnbaumer, L. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 1703-1708[Abstract/Free Full Text]
  72. Zamponi, G. W., Bourinet, E., Nelson, D., Nargeot, J., and Snutch, T. P. (1997) Nature 385, 442-446[CrossRef][Medline] [Order article via Infotrieve]
  73. Koch, W. J., Ellinor, P. T., and Schwartz, A. (1990) J. Biol. Chem. 265, 17786-17791[Abstract/Free Full Text]
  74. Soldatov, N. M. (1994) Genomics 22, 77-87[CrossRef][Medline] [Order article via Infotrieve]
  75. Slish, D. F., Engle, D. B., Varadi, G., Lotan, I., Singer, D., Dascal, N., and Schwartz, A. (1989) FEBS Lett. 250, 509-514[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.